Mon, Mar 2, 2015, 9:02 AM EST - U.S. Markets open in 28 mins.


% | $
Quotes you view appear here for quick access.

Astex Pharmaceuticals, Inc. Message Board

  • vvvvvvrebel89130 vvvvvvrebel89130 Sep 5, 2013 8:19 AM Flag

    brean still with target of $13; says reject deal

    Astex Pharmaceuticals' buyout offer by Otsuka too low, says Brean Capital
    Brean Capital believes Otsuka's $8.50 per share buyout offer for Astex Pharmaceuticals is too low and does not fully reflect the value of Dacogen royalties, SGI-110 potential, or its portfolio of partnered compounds. The analyst believes Astex should reject any offer below $13 per share and reiterates its Buy rating and $13 price target.

    Sentiment: Strong Buy

8.495+0.0150(+0.18%)Oct 10 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.